In this note, while we briefly touch upon Pfizer’s performance in 2024, we focus on the impact on PFE stock and how 2025 ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...

For many investors, the main point of stock picking is to generate higher returns than the overall market. But if ...

Pfizer Inc. (NYSE:PFE – Get Free Report) saw unusually large options trading activity on Thursday. Traders acquired 251,131 ...

Citi analyst Geoff Meacham maintained a Hold rating on Pfizer (PFE – Research Report) today. The company’s shares closed yesterday at ...

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

Pfizer on Thursday said it will raise its quarterly dividend by 2.4%. The New York-based drug company on Thursday said its board increased its cash dividend to 43 cents a share from 42 cents.

Pfizer's stock experienced a notable decline on Friday at the New York Stock Exchange, falling 1.6% to $26.03 per share following news of a $59.7 million settlement payment. The settlement stems from ...

Pfizer Inc. expects to inform employees ... The company’s stock price has dropped about 24% on the New York Stock Exchange in ...

Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $32.00. The ...

Pfizer on Tuesday appealed a federal judge's refusal to award the drugmaker $75.2 million from a more than decade-old insider ...

NEW YORK (Reuters ... U.S. Securities and Exchange Commission over trades in drugmakers Wyeth and Elan by Mathew Martoma, who worked at an SAC unit and was later convicted. Pfizer said it ...